Galapagos | Driftsresultat

Operating Profit Lave om Dato
AstraZeneca USD 1.95B 502M 2023-09
Genmab DKK 1.72B 220M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
GRIFOLS EUR 254.78M 4.2M 2023-12
Hikma Pharmaceutical USD 243M 183M 2023-06
Incyte USD 187.27M 27.44M 2023-12
Merck EUR 983M 14M 2023-09
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Roche Holding CHF 9.76B 3.84B 2023-06
UCB EUR 480M 385M 2023-06
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Galapagos Driftsresultat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.